#HiringAlert: We’re searching for a Director, Medical Writing to provide technical and medical writing support across key areas, including #CMC, nonclinical, clinical regulatory submissions and others. This individual will also work closely with medical writing consultants and vendors to oversee the development, review, and approval of clinical and regulatory documents, ensuring that all written materials are accurate, clear, and compliant throughout the submission process. Interested in learning more? Visit: https://lnkd.in/eGP2ggRC #WeAreHiring #Hiring
Sionna Therapeutics
生物技术
Boston,MA 6,299 位关注者
Dedicated to delivering therapies that could be transformational for people living with cystic fibrosis.
关于我们
We are a life sciences company that is building on over a decade of extensive research on the genetic mutations associated with cystic fibrosis. We are developing first-in-class small molecules that are focused on a unique target with the potential to fully normalize CFTR function for the first time for the vast majority of people living with CF.
- 网站
-
https://www.sionnatx.com/
Sionna Therapeutics的外部链接
- 所属行业
- 生物技术
- 规模
- 11-50 人
- 总部
- Boston,MA
- 类型
- 私人持股
- 创立
- 2019
- 领域
- life sciences、biotechnology、pharmaceuticals、cystic fibrosis、protein function、genetics、genetic mutation、genetic disease、clinical research、clinical study、research、small molecule、molecular engineering、chemistry、patient advocacy、drug development、clinical development、lung、orphan disease和rare disease
地点
-
主要
US,MA,Boston
Sionna Therapeutics员工
动态
-
Today we reported our financial results for the fourth quarter and full year of 2024 and provided a business update.?? ? Read our press release for details: https://lnkd.in/eCpvKxUE
-
-
March is #NationalNutritionMonth, a time to spotlight the essential role nutrition plays in managing cystic fibrosis (CF). For those with #CF, proper nutrition is especially important for maintaining health, supporting lung function, and preventing malnutrition. As we work to deliver clinically meaningful benefits to people living with CF, we remain dedicated to raising awareness of the unique challenges these individuals face. Learn more about the significance of nutrition in CF care with insights from the Cystic Fibrosis Foundation: https://lnkd.in/eUcn6FkM
-
In the past three decades, significant advancements have been made in the treatment and management of cystic fibrosis (CF), transforming the diagnosis, prognosis, and quality of life?for?many living with the condition.? We’re proud to be part of this progress as we continue to advance our pipeline of #CF therapies. Learn more: https://lnkd.in/g_JNv62P
-
-
#WeAreHiring a Vice President, Head of Medical Affairs to join our growing team. This leadership role offers a unique opportunity to establish and oversee Sionna’s Medical Affairs strategy and function across all programs. The successful candidate will work closely with our Chief Medical Officer, playing a key part in building and managing the Medical Affairs infrastructure, supporting scientific communications, and fostering collaboration across clinical development and commercial functions. Learn more: https://lnkd.in/eMxzYMkx #HiringAlert #Hiring #JoinOurTeam
-
-
At Sionna, we are committed to fostering a culture of inclusivity and empowerment. In celebration of International Women’s Day, we are proud to highlight the recent appointments of three remarkable women—Laurie Stelzer, Marcie Ruddy, M.D., and Jo Viney, Ph.D.—to our Board of Directors.??? ?? As we continue to grow and advance our mission to revolutionize the treatment paradigm for cystic fibrosis (CF), their leadership will be instrumental in driving our progress forward. We are honored to collaborate with them as they inspire and pave the way for future leaders in the field.?#IWD #InternationalWomensDay
-
-
In honor of International Women’s Day, our newly appointed VP, Talent, Roxanne McGrath, reflects on the trailblazing women throughout history whose courage and resilience have paved the way for others—including herself—to confidently pursue their dreams.? ? Thanks for sharing, Roxanne. We’re proud to have you on our team! #IWD #InternationalWomensDay #InspireInclusion?
-
-
#ICYMI we announced the appointments of Marcie Ruddy, M.D., and Jo Viney, Ph.D., to our Board of Directors.? We look forward to leveraging their experience as we strive to develop medicines designed to normalize the function of the CFTR protein. For details: https://lnkd.in/efVQwhyJ?
-
-
Thanks for spotlighting us as a #MassBioMember as we celebrate new milestones! As we work to develop our portfolio of cystic fibrosis (#CF) therapies, we’re proud to be part of this community of innovative companies and industry leaders.?
Sionna Therapeutics?is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein. Sionna is leveraging over a decade of extensive research to advance a pipeline of differentiated small molecules engineered to stabilize CFTR’s nucleotide-binding domain 1 (NBD1), where the most common cystic fibrosis genetic mutation F508del resides. Sionna is also developing a portfolio of complementary CFTR modulators that are designed to work synergistically with its NBD1 stabilizers to improve CFTR activity, which Sionna believes is central to unlocking dramatic improvements in clinical outcomes and quality of life for cystic fibrosis patients. #MassBioMember Spotlight:?Sionna Therapeutics Location:?Waltham, MA Website: sionnatx.com Leadership: Michael Cloonan, President and Chief Executive Officer | Charlotte McKee, M.D., Chief Medical Officer | Elena Ridloff, CFA, Chief Financial Officer & Head of Corporate Development | Vanya Sagar, Chief People Officer | Greg Hurlbut, Ph.D., Co-Founder and Senior Vice President, Discovery Research | Mark M., Ph.D., Co-Founder and Senior Vice President, Medicinal Chemistry Therapeutic Area:?Cystic Fibrosis #patientdriven #massbiomembers #cysticfibrosis
-
-
Exciting progress as we work to restore #CFTR function for people with cystic fibrosis (#CF)! Thank you, Atlas Venture, for your continued support throughout our IPO journey and beyond.?
Congratulations to the team at Sionna Therapeutics on their recent IPO! Learn more about the work they are doing to revolutionize the current treatment paradigm for cystic fibrosis patients here: https://www.sionnatx.com/ #NASDAQListed #doingwellbydoinggood #biotechipo
-